PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 1.525 AUD -0.65% Market Closed
Market Cap: 889.5m AUD

Intrinsic Value

The intrinsic value of one PYC stock under the Base Case scenario is hidden AUD. Compared to the current market price of 1.525 AUD, PYC Therapeutics Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

PYC Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
PYC Therapeutics Ltd

Intrinsic Value History
Dive into the past to invest in the future

PYC looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if PYC is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about PYC?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PYC valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for PYC Therapeutics Ltd.

Explain Valuation
Compare PYC to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

PYC Therapeutics’ valuation hinges on the success of its lead candidate targeting inherited retinal diseases, and any setback in clinical trials could severely diminish investor confidence and heighten the company’s cash burn rate.

Bull Theses

PYC Therapeutics’ precision RNA platform has shown promising preclinical data that could pave the way for a breakthrough therapy in inherited retinal diseases, unlocking substantial market potential for targeted treatments.

Show More Less
How do you feel about PYC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
PYC Therapeutics Ltd

Current Assets 177.5m
Cash & Short-Term Investments 153.1m
Receivables 24.1m
Other Current Assets 407.8k
Non-Current Assets 5.8m
PP&E 1.9m
Intangibles 3.9m
Current Liabilities 12.3m
Accounts Payable 8.8m
Accrued Liabilities 2.6m
Other Current Liabilities 918.1k
Non-Current Liabilities 1.4m
Long-Term Debt 625k
Other Non-Current Liabilities 763.7k
Efficiency

Free Cash Flow Analysis
PYC Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PYC Therapeutics Ltd

Revenue
26.2m AUD
Operating Expenses
-75.9m AUD
Operating Income
-49.7m AUD
Other Expenses
-557.9k AUD
Net Income
-50.3m AUD
Fundamental Scores

PYC Profitability Score
Profitability Due Diligence

PYC Therapeutics Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Declining Net Margin
Low Gross Margin
Declining Operating Margin
hidden
Profitability
Score

PYC Therapeutics Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

PYC Solvency Score
Solvency Due Diligence

PYC Therapeutics Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

PYC Therapeutics Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PYC Price Targets Summary
PYC Therapeutics Ltd

Wall Street analysts forecast PYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PYC is 3.719 AUD with a low forecast of 2.323 AUD and a high forecast of 5.334 AUD.

Lowest
Price Target
2.323 AUD
52% Upside
Average
Price Target
3.719 AUD
144% Upside
Highest
Price Target
5.334 AUD
250% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

PYC Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for PYC is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PYC stock?

The intrinsic value of one PYC stock under the Base Case scenario is hidden AUD.

Is PYC stock undervalued or overvalued?

Compared to the current market price of 1.525 AUD, PYC Therapeutics Ltd is hidden .

Back to Top